Role of DYT1 Mutation in Dystonia
Role of DYT1 Mutation in Dystonia
批准号:
7196417
负责人:
NUTAN SHARMA
金额:
$17.06万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2009-02-28
关键词:
Acetic AcidAcetic AcidsBasal GangliaBehaviorDevelopmentDopamineDopamine ReceptorDopaminergic CellDystoniaEarly Onset DystoniaEnergy TransferEnvironmental Risk FactorExhibitsExposure toFractionationGAG GeneGenerationsGeneticHigh Pressure Liquid ChromatographyHomovanillic AcidHumanImmunohistochemistryImmunoprecipitationIndividualInheritedInjection of therapeutic agentMiningMolecular ChaperonesMotorMusMutationNeuronsNumbersPathway interactionsPenetrancePhenotypePresynaptic TerminalsPrincipal InvestigatorProcessProteinsRoleStressTimeTorsinATransgenic MiceTransgenic OrganismsViral Vectoralpha synucleindensitydopaminergic neuronmutantprogramssizetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The most common cause of early onset dystonia is DYT1 dystonia. DYT1 dystonia is inherited in an autosomal dominant manner with 30-40% penetrance. The DYT1 mutation is a GAG deletion near the carboxy terminus of the protein, torsin A. At this time, the function of torsin A is unknown. The lack of phenotypic expression in 60% to70% of individuals with the DYT1 mutation indicates that secondary factors (environmental or genetic) must operate in conjunction with the DYT1 mutation to result in a dystonic phenotype. To determine the role of the DYT1 mutation in generating a dystonic phenotype, transgenic mice expressing either wild-type or mutant torsin A will be systemically examined for motor abnormalities. The mice will also be subject to dopamine blockade, to investigate the role of environmental stress in the generation of a dystonic phenotype. To determine if basal ganglia expression of the DYT1 mutation is sufficient for development of a dystonic phenotype, mice will undergo intrastriatal injection with a viral vector expressing either wild-type or mutant torsin A. The injected mice will be examined for changes in phenotype as well as for changes in dopaminergic transmission via HPLC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Variants in Craniofacial Dystonias
-
批准号:10364887
-
项目类别:
-
资助金额:$61.88万
-
财政年份:2022
-
负责人:NUTAN SHARMA
-
依托单位:
Genetic Variants in Craniofacial Dystonias
-
批准号:10686185
-
项目类别:
-
资助金额:$60.18万
-
财政年份:2022
-
负责人:NUTAN SHARMA
-
依托单位:
Natural history study of x-linked Dystonia Parkinsonism
-
批准号:10181089
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2020
-
负责人:NUTAN SHARMA
-
依托单位:
Natural history study of x-linked Dystonia Parkinsonism
-
批准号:10053483
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2020
-
负责人:NUTAN SHARMA
-
依托单位:
FOCAL DYSTONIA: GENOTYPE-PHENOTYPE CORRELATION
-
批准号:7731292
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2008
-
负责人:NUTAN SHARMA
-
依托单位:
THE DYT1 MUTATION IN DYSTONIA
-
批准号:6613663
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2003
-
负责人:NUTAN SHARMA
-
依托单位:
THE ROLE OF THE DYT1 MUTATION IN DYSTONIA
-
批准号:6740863
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2003
-
负责人:NUTAN SHARMA
-
依托单位:
THE ROLE OF THE DYT1 MUTATION IN DYSTONIA
-
批准号:6848881
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2003
-
负责人:NUTAN SHARMA
-
依托单位:
THE ROLE OF THE DYT1 MUTATION IN DYSTONIA
-
批准号:7022189
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2003
-
负责人:NUTAN SHARMA
-
依托单位:
Clinical Core
-
批准号:8149948
-
项目类别:
-
资助金额:$39.0万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Core B Clinical Core
-
批准号:9085424
-
项目类别:
-
资助金额:$30.15万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Clinical Core
-
批准号:7798806
-
项目类别:
-
资助金额:$32.13万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Core B Clinical Core
-
批准号:8854419
-
项目类别:
-
资助金额:$30.15万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Clinical Core
-
批准号:8301696
-
项目类别:
-
资助金额:$39.0万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Clinical Core
-
批准号:8378369
-
项目类别:
-
资助金额:$37.93万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
Clinical Core
-
批准号:8512804
-
项目类别:
-
资助金额:$36.6万
-
财政年份:--
-
负责人:NUTAN SHARMA
-
依托单位:
海外基金